Lipid Binding Proteins in Obesity and Diabetes Syndromes
Lipid Binding Proteins in Obesity and Diabetes Syndromes
批准号:
8637053
负责人:
David A Bernlohr
金额:
$33.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-12 至 2017-03-31
关键词:
AdipocytesAdipose tissueAdultAnabolismAnimal ModelAsthmaAttenuatedBindingBinding ProteinsBiologyCCL2 geneCardiovascular DiseasesCell Culture TechniquesCell LineCharacteristicsCytokine SignalingDevelopmentDiabetes MellitusDietEicosanoidsEnzymesExhibitsFatty AcidsFatty acid glycerol estersForskolinGene ExpressionGenetic PolymorphismHealthHeart HypertrophyHumanHuman BiologyHyperlipidemiaHypersensitivityHypertensionHypertriglyceridemiaInflammationInflammatoryInsulinInsulin ResistanceInvestigationKnockout MiceLaboratoriesLeadLeukotriene A4Leukotriene B4Leukotriene C4Leukotriene D4Leukotriene E4LeukotrienesLinkLipid BindingLipidsLipolysisMediatingMetabolic DiseasesMetabolic syndromeMetabolismModelingMolecularMonounsaturated Fatty AcidsMusNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsObesityOverweightPathologyPeroxisome Proliferator-Activated ReceptorsPhosphorylationPhysiologicalPlayPredispositionProcessProductionProto-Oncogene Proteins c-aktRiskRoleSaturated Fatty AcidsSecond Messenger SystemsSumSurveysSyndromeTNF geneTestingThrombosisUnited StatesUnited States National Institutes of HealthVisceralWorkadiponectincysteinyl-leukotrienecytokineendothelial dysfunctionfatty acid-binding proteinsglucose transportimprovedinsulin sensitivityinsulin signalingmacrophagemolecular sitemonocytemouse modelpromoterreceptorsecond messenger
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Fatty acid binding proteins (FABPS) are intracellular free fatty acid receptors found expressed at high levels in adipocytes and macrophages. FABPs bind a variety of unesterified fatty acids and other lipid second messengers and mediate their intracellular metabolism. When placed on high fat diets, FABP knockout mice exhibit attenuated characteristics of the metabolic syndrome including diminished adipocyte lipolysis, reduced TNF¿ and increased adiponectin expression, improved insulin sensitivity, decreased NF-?B activation, protection from asthma and diminished atherogenic capacity. In contrast, mice over-expressing FABP in adipose tissue exhibit potentiated characteristics of the metabolic syndrome included increased lipolysis, exacerbated insulin resistance, decreased adiponectin secretion, and mild cardiac hypertrophy. Humans with decreased adipocyte FABP (arising via a polymorphism in the AFABP/aP2 promoter) exhibit reduced risk for hypertriglyceridemia, type 2 diabetes and cardiovascular disease. In work carried out under NIH DK053189 we have demonstrated that the FABPs of adipose tissue are required for inflammatory leukotriene biosynthesis. Since LTA4 is a precursor to the monocyte recruitment factor LTB4 and the inflammatory cysteinyl leukotrienes (LTC4, LTD4 and LTE4), adipose tissue from FABP null mice and FABP null macrophage cell lines exhibit reduced levels of inflammatory eicosanoids. Treatment of macrophages with leukotrienes results in an increase in iNOS and MCP1 expression while decreasing PPAR?. Moreover, LTC4 treatment of adipocytes results in decreased phosphorylation of Akt and attenuated glucose transport while increasing basal and forskolin-stimulated lipolysis. These findings lead to the hypothesis that: fatty acids, either fro diet or from adipocyte lipolysis, stimulate resident macrophages resulting in fatty acid binding protein-dependent leukotriene synthesis. LTB4 and LTC4 promote inflammatory gene expression and cytokine secretion by macrophages, and LTC4 impairs insulin signaling, alters adipokine secretion and increases lipolysis in adipocytes. To test this hypothesis, we propose the following four specific aims: 1. Determine the role of fatty acids and fatty acid binding proteins in macrophage leukotriene biosynthesis using cell culture models. 2. Assess the role of fatty acids and fatty acid binding proteins in adipose tissue leukotriene biosynthesis using animal models. 3. Evaluate the interaction of FABPs with LTA4 and LTA4 metabolizing enzymes. 4. Examine the effects of leukotrienes on macrophage and adipocyte signal transduction and cytokine synthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Midwest Murine-Tissue Mapping Center (MM-TMC)
-
批准号:10552986
-
项目类别:
-
资助金额:$270.0万
-
财政年份:2022
-
负责人:David A Bernlohr
-
依托单位:
Midwest Murine-Tissue Mapping Center (MM-TMC)
-
批准号:10675007
-
项目类别:
-
资助金额:$270.0万
-
财政年份:2022
-
负责人:David A Bernlohr
-
依托单位:
Administrative Core
-
批准号:10675008
-
项目类别:
-
资助金额:$72.07万
-
财政年份:2022
-
负责人:David A Bernlohr
-
依托单位:
Administrative Core
-
批准号:10552987
-
项目类别:
-
资助金额:$50.71万
-
财政年份:2022
-
负责人:David A Bernlohr
-
依托单位:
Inflammation, Lipid Metabolism and Senescence
-
批准号:10264042
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2020
-
负责人:David A Bernlohr
-
依托单位:
Inflammation, Lipid Metabolism and Senescence
-
批准号:10661613
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2020
-
负责人:David A Bernlohr
-
依托单位:
Inflammation, Lipid Metabolism and Senescence
-
批准号:10432085
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2020
-
负责人:David A Bernlohr
-
依托单位:
Inflammation, Lipid Metabolism and Senescence
-
批准号:10094457
-
项目类别:
-
资助金额:$37.01万
-
财政年份:2020
-
负责人:David A Bernlohr
-
依托单位:
Molecular and Cellular Basis of Obesity Core
-
批准号:8132707
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2011
-
负责人:David A Bernlohr
-
依托单位:
Mitochondrial Dysfunction and Adipose Insulin Resistance
-
批准号:8531229
-
项目类别:
-
资助金额:$29.98万
-
财政年份:2010
-
负责人:David A Bernlohr
-
依托单位:
Mitochondrial Dysfunction and Adipose Insulin Resistance
-
批准号:7893525
-
项目类别:
-
资助金额:$37.41万
-
财政年份:2010
-
负责人:David A Bernlohr
-
依托单位:
Mitochondrial Dysfunction and Adipose Insulin Resistance
-
批准号:8706849
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2010
-
负责人:David A Bernlohr
-
依托单位:
Mitochondrial Dysfunction and Adipose Insulin Resistance
-
批准号:8298244
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2010
-
负责人:David A Bernlohr
-
依托单位:
Mitochondrial Dysfunction and Adipose Insulin Resistance
-
批准号:8059616
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2010
-
负责人:David A Bernlohr
-
依托单位:
Mitochondrial Dysfunction and Adipose Insulin Resistance
-
批准号:7847293
-
项目类别:
-
资助金额:$18.54万
-
财政年份:2009
-
负责人:David A Bernlohr
-
依托单位:
Lipid Binding in Obesity/Diabetes Syndromes
-
批准号:7996303
-
项目类别:
-
资助金额:$9.78万
-
财政年份:2009
-
负责人:David A Bernlohr
-
依托单位:
Obesity and Energy Metabolism Core
-
批准号:7120310
-
项目类别:
-
资助金额:$16.63万
-
财政年份:2006
-
负责人:David A Bernlohr
-
依托单位:
Lipid Binding in Obesity/Diabetes Syndromes
-
批准号:7322863
-
项目类别:
-
资助金额:$29.94万
-
财政年份:1998
-
负责人:David A Bernlohr
-
依托单位:
Lipid Binding in Obesity/Diabetes Syndromes
-
批准号:7638529
-
项目类别:
-
资助金额:$29.81万
-
财政年份:1998
-
负责人:David A Bernlohr
-
依托单位:
Lipid Binding in Obesity/Diabetes Syndromes
-
批准号:7998840
-
项目类别:
-
资助金额:$7.87万
-
财政年份:1998
-
负责人:David A Bernlohr
-
依托单位:
海外基金